Avantax Advisory Services Inc. Purchases 364 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Avantax Advisory Services Inc. grew its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 8.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,669 shares of the company’s stock after purchasing an additional 364 shares during the quarter. Avantax Advisory Services Inc.’s holdings in HCA Healthcare were worth $1,264,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Kinetic Partners Management LP bought a new stake in HCA Healthcare in the 3rd quarter valued at about $50,524,000. EP Wealth Advisors LLC increased its holdings in shares of HCA Healthcare by 501.8% during the third quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company’s stock valued at $51,401,000 after acquiring an additional 174,240 shares in the last quarter. Retirement Systems of Alabama grew its position in HCA Healthcare by 350.0% in the 4th quarter. Retirement Systems of Alabama now owns 204,812 shares of the company’s stock valued at $55,439,000 after purchasing an additional 159,303 shares during the period. Canada Pension Plan Investment Board raised its holdings in HCA Healthcare by 51.6% during the third quarter. Canada Pension Plan Investment Board now owns 355,730 shares of the company’s stock worth $87,502,000 after buying an additional 121,100 shares during the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of HCA Healthcare by 83.4% during the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 254,408 shares of the company’s stock valued at $62,579,000 after buying an additional 115,720 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.0 %

HCA opened at $322.86 on Friday. The company has a market cap of $84.56 billion, a PE ratio of 16.09, a price-to-earnings-growth ratio of 1.50 and a beta of 1.66. The company has a 50 day moving average of $319.96 and a 200 day moving average of $303.37. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $335.83. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the prior year, the firm posted $4.93 EPS. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 20.79 EPS for the current year.

HCA Healthcare declared that its Board of Directors has approved a share buyback program on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 7.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.82%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now owns 1,576 shares of the company’s stock, valued at $520,474. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The disclosure for this sale can be found here. Insiders sold a total of 13,617 shares of company stock worth $4,321,986 over the last ninety days. 1.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Barclays lifted their price target on HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research note on Monday, April 29th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Finally, Truist Financial upped their target price on HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $317.00.

Get Our Latest Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.